Mayflower Financial Advisors, LLC Novo Cure LTD Transaction History

Mayflower Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$56.44 - $118.81 $282 - $594	5 Added 0.14%	3,518 $211,000
Q4 2022 Jan 25, 2023	BUY	$63.98 - $85.37 $224,761 - $299,904	3,513 New	3,513 $0
Q3 2022 Oct 19, 2022	BUY	$67.99 - $89.57 $239,324 - $315,286	3,520 New	3,520 $267,000
Q2 2022 Jul 15, 2022	BUY	$56.6 - $89.9 $396 - $629	7 Added 0.2%	3,516 $244,000
Q4 2021 Jan 21, 2022	BUY	$75.08 - $121.99 $150 - $243	2 Added 0.06%	3,509 $263,000
Q4 2020 Apr 12, 2021	BUY	$112.16 - $174.14 $393,345 - $610,708	3,507 New	3,507 $607,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.